197 related articles for article (PubMed ID: 19631303)
41. Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF).
Chapman I; Greville H; Ebeling PR; King SJ; Kotsimbos T; Nugent P; Player R; Topliss DJ; Warner J; Wilson JW
Clin Endocrinol (Oxf); 2009 Jun; 70(6):838-46. PubMed ID: 18823395
[TBL] [Abstract][Full Text] [Related]
42. Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism.
Nissen-Meyer LS; Svalheim S; Taubøll E; Reppe S; Lekva T; Solberg LB; Melhus G; Reinholt FP; Gjerstad L; Jemtland R
Epilepsia; 2007 Oct; 48(10):1850-60. PubMed ID: 17634065
[TBL] [Abstract][Full Text] [Related]
43. Staged-injection procedure to prevent cement leakage during vertebroplasty: an in vitro study.
Wu ZX; Wei L; Hu YY; Wang HQ; Wan SY; Wang J; Han Y
Spine (Phila Pa 1976); 2007 Oct; 32(22):2437-42. PubMed ID: 18090082
[TBL] [Abstract][Full Text] [Related]
44. Long-term effects of intermittent androgen suppression on testosterone recovery and bone mineral density: results of a 33-month observational study.
Spry NA; Galvão DA; Davies R; La Bianca S; Joseph D; Davidson A; Prince R
BJU Int; 2009 Sep; 104(6):806-12. PubMed ID: 19281463
[TBL] [Abstract][Full Text] [Related]
45. Effects of two low-dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study.
Gargano V; Massaro M; Morra I; Formisano C; Di Carlo C; Nappi C
Contraception; 2008 Jul; 78(1):10-5. PubMed ID: 18555812
[TBL] [Abstract][Full Text] [Related]
46. Effect of glucagon-like peptide-2 exposure on bone resorption: Effectiveness of high concentration versus prolonged exposure.
Askov-Hansen C; Jeppesen PB; Lund P; Hartmann B; Holst JJ; Henriksen DB
Regul Pept; 2013 Feb; 181():4-8. PubMed ID: 23261963
[TBL] [Abstract][Full Text] [Related]
47. The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial.
Pullerits R; d'Elia HF; Tarkowski A; Carlsten H
Rheumatology (Oxford); 2009 Jul; 48(7):785-90. PubMed ID: 19416946
[TBL] [Abstract][Full Text] [Related]
48. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
Recker RR; Bare SP; Smith SY; Varela A; Miller MA; Morris SA; Fox J
Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
[TBL] [Abstract][Full Text] [Related]
49. Subcutaneous GIP and GLP-2 inhibit nightly bone resorption in postmenopausal women: A preliminary study.
Skov-Jeppesen K; Veedfald S; Madsbad S; Holst JJ; Rosenkilde MM; Hartmann B
Bone; 2021 Nov; 152():116065. PubMed ID: 34153529
[TBL] [Abstract][Full Text] [Related]
50. A double-blinded head-to-head trial of minodronate and alendronate in women with postmenopausal osteoporosis.
Hagino H; Nishizawa Y; Sone T; Morii H; Taketani Y; Nakamura T; Itabashi A; Mizunuma H; Ohashi Y; Shiraki M; Minamide T; Matsumoto T
Bone; 2009 Jun; 44(6):1078-84. PubMed ID: 19264155
[TBL] [Abstract][Full Text] [Related]
51. The effects of variations in dose and method of administration on glucagon like peptide-2 activity in the rat.
Kaji T; Tanaka H; Holst JJ; Redstone H; Wallace L; de Heuval E; Sigalet DL
Eur J Pharmacol; 2008 Oct; 596(1-3):138-45. PubMed ID: 18762180
[TBL] [Abstract][Full Text] [Related]
52. Low dose beta-blocker prevents ovariectomy-induced bone loss in rats without affecting heart functions.
Bonnet N; Benhamou CL; Malaval L; Goncalves C; Vico L; Eder V; Pichon C; Courteix D
J Cell Physiol; 2008 Dec; 217(3):819-27. PubMed ID: 18727092
[TBL] [Abstract][Full Text] [Related]
53. Effect of pamidronate on bone loss after kidney transplantation: a randomized trial.
Walsh SB; Altmann P; Pattison J; Wilkie M; Yaqoob MM; Dudley C; Cockwell P; Sweny P; Banks LM; Hall-Craggs M; Noonan K; Andrews C; Cunningham J
Am J Kidney Dis; 2009 May; 53(5):856-65. PubMed ID: 19393473
[TBL] [Abstract][Full Text] [Related]
54. The effects of weight bearing yoga training on the bone resorption markers of the postmenopausal women.
Phoosuwan M; Kritpet T; Yuktanandana P
J Med Assoc Thai; 2009 Sep; 92 Suppl5():S102-8. PubMed ID: 19891384
[TBL] [Abstract][Full Text] [Related]
55. Manganese supplementation improves mineral density of the spine and femur and serum osteocalcin in rats.
Bae YJ; Kim MH
Biol Trace Elem Res; 2008 Jul; 124(1):28-34. PubMed ID: 18330520
[TBL] [Abstract][Full Text] [Related]
56. Pharmacokinetics, safety, and tolerability of teduglutide, a glucagon-like peptide-2 (GLP-2) analog, following multiple ascending subcutaneous administrations in healthy subjects.
Marier JF; Beliveau M; Mouksassi MS; Shaw P; Cyran J; Kesavan J; Wallens J; Zahir H; Wells D; Caminis J
J Clin Pharmacol; 2008 Nov; 48(11):1289-99. PubMed ID: 18974283
[TBL] [Abstract][Full Text] [Related]
57. Intravenous neridronate for skeletal damage treatment in patients with multiple myeloma.
Pittari G; Costi D; Raballo M; Maulucci L; Baroni MC; Mangoni M
Acta Biomed; 2006 Aug; 77(2):81-4. PubMed ID: 17172186
[TBL] [Abstract][Full Text] [Related]
58. Effect of microdose transdermal 17beta-estradiol compared with raloxifene in the prevention of bone loss in healthy postmenopausal women: a 2-year, randomized, double-blind trial.
Schaefers M; Muysers C; Alexandersen P; Christiansen C
Menopause; 2009; 16(3):559-65. PubMed ID: 19423999
[TBL] [Abstract][Full Text] [Related]
59. [Therapeutic agents for disorders of bone and calcium metabolism. Development of nasal formulation of hPTH (1-34)].
Sato K
Clin Calcium; 2007 Jan; 17(1):64-71. PubMed ID: 17211095
[TBL] [Abstract][Full Text] [Related]
60. Major depression is a risk factor for low bone mineral density: a meta-analysis.
Yirmiya R; Bab I
Biol Psychiatry; 2009 Sep; 66(5):423-32. PubMed ID: 19446797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
